Rocket Pharmaceuticals Inc (RCKT) — Net Asset Quality Index
Rocket Pharmaceuticals Inc (RCKT) has a Net Asset Quality Index of 83.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $285.41 Million minus total liabilities of $47.37 Million yields net assets of $238.04 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RCKT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rocket Pharmaceuticals Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Rocket Pharmaceuticals Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 83.4%, representing net assets of $238.04 Million against total assets of $285.41 Million USD. See Rocket Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Rocket Pharmaceuticals Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Rocket Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Rocket Pharmaceuticals Inc (RCKT) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.9% | $277.22 Million | $330.45 Million | $53.23 Million | ▼ -3.9 pp |
| 2024 | 87.8% | $463.23 Million | $527.70 Million | $64.47 Million | ▲ +0.8 pp |
| 2023 | 87.0% | $492.57 Million | $566.34 Million | $73.77 Million | ▼ -1.8 pp |
| 2022 | 88.7% | $489.69 Million | $551.81 Million | $62.12 Million | ▼ -2.7 pp |
| 2021 | 91.5% | $454.72 Million | $497.02 Million | $42.30 Million | ▲ +6.3 pp |
| 2020 | 85.2% | $503.52 Million | $590.82 Million | $87.31 Million | ▲ +2.6 pp |
| 2019 | 82.6% | $307.30 Million | $372.12 Million | $64.82 Million | ▲ +5.4 pp |
| 2018 | 77.2% | $194.04 Million | $251.31 Million | $57.28 Million | ▲ +30.3 pp |
| 2017 | 46.9% | $47.76 Million | $101.78 Million | $54.01 Million | ▼ -9.5 pp |
| 2016 | 56.4% | $73.17 Million | $129.65 Million | $56.48 Million | ▼ -39.6 pp |
| 2015 | 96.0% | $108.81 Million | $113.32 Million | $4.51 Million | ▲ +1030.1 pp |
| 2014 | -934.0% | $-51.56 Million | $5.52 Million | $57.08 Million | ▼ -631.7 pp |
| 2013 | -302.4% | $-38.90 Million | $12.86 Million | $51.76 Million | ▲ +1874.3 pp |
| 2012 | -2176.6% | $-30.93 Million | $1.42 Million | $32.35 Million | — |